Press Releases Tectonic Therapeutic, Inc.

Equities

AVRO

US8789721086

Real-time Estimate Cboe BZX Other stock markets 15:34:30 2024-06-27 EDT			5-day change	1st Jan Change
16.4 ^USD	+2.92%		-6.51%	-2.39%

06-20	Avrobio Closes Merger With Tectonic Therapeutic	MT
06-20	Tectonic Therapeutic, Inc. announced that it has received $96.599856 million in funding from Tas Partners, LLC	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

AVROBIO INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of AVROBIO, Inc. - AVRO	05-09	BU
Tectonic Therapeutic Initiates Phase 1B Study for TX45 in Group 2 Pulmonary Hypertension in Patients with Preserved Ejection Fraction Heart Failure	03-27	AQ
AVROBIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AVROBIO, Inc. - AVRO	02-14	BU
Shareholder Alert: Ademi LLP investigates whether AVROBIO, Inc. has obtained a Fair Price in its transaction with Tectonic	01-31	PR
AVRO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of AVROBIO, Inc. Is Fair to Shareholders	01-30	BU
AVROBIO and Tectonic Therapeutic Announce Merger	01-30	BU
AVROBIO to Explore Strategic Alternatives	23-07-12	BU
AVROBIO : UNAUDITED PRO FORMA FINANCIAL INFORMATION - Form 8-K	23-06-12	PU
AVROBIO Completes Sale of Cystinosis Gene Therapy Program for $87.5 Million	23-06-12	BU
BigTime Penny Stocks: Rapid Growth in Gene Therapy Market (GNPX, LEAS;RWOD, VYGR, AVRO)	23-06-01	AQ
AVROBIO Announces Agreement to Sell Cystinosis Gene Therapy Program for $87.5 Million	23-05-22	BU
AVROBIO : ASGCT Cystinosis Update May 2023	23-05-18	PU
AVROBIO Announces Positive Data from Phase 1/2 Clinical Trial of Investigational Gene Therapy for Cystinosis at the ASGCT 26th Annual Meeting	23-05-18	BU
AVROBIO, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	23-05-11	AQ
AVROBIO Reports First Quarter 2023 Financial Results and Provides Business Update	23-05-11	BU
AVROBIO, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-05-01	AQ
AVROBIO Announces Leadership Transition	23-05-01	BU
AVROBIO, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	23-03-23	AQ
AVROBIO, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	23-03-23	AQ
AVROBIO Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Update	23-03-23	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Tectonic Therapeutic, Inc.

Equities

AVRO

US8789721086

Press Releases

Filters